NEOPLASMS BY SITE
Clinical trials for NEOPLASMS BY SITE explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS BY SITE trials appear
Sign up with your email to follow new studies for NEOPLASMS BY SITE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise against tough cancers
Disease control CompletedThis study tested an experimental drug (BMS-986016) that targets LAG-3, a protein that can help tumors hide from the immune system. The drug was given alone or with nivolumab (a PD-1 blocker) to people with advanced solid tumors that had spread or couldn't be removed by surgery. …
Matched conditions: NEOPLASMS BY SITE
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 17, 2026 03:00 UTC
-
New shot version of cancer drug shows promise in early study
Disease control CompletedThis study tested a new way to give the cancer drug nivolumab: as a shot under the skin instead of through an IV. It included 139 people with advanced cancers like lung, kidney, melanoma, liver, and colorectal cancer. The main goal was to see how the drug behaves in the body and …
Matched conditions: NEOPLASMS BY SITE
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Experimental CAR-T therapy targets tough blood cancers in small early trial
Disease control CompletedThis early-phase study tested a new treatment called RD13-02, which uses a patient's own immune cells modified to attack cancer cells with a specific marker (CD7). It involved just 2 people with blood cancers like T-cell acute lymphoblastic leukemia that had come back or not resp…
Matched conditions: NEOPLASMS BY SITE
Phase: EARLY_PHASE1 • Sponsor: MEI HENG • Aim: Disease control
Last updated May 04, 2026 16:24 UTC
-
New scan spots cancers standard MRI misses
Diagnosis CompletedThis study tested whether advanced PET-MRI scans can find prostate cancers that standard MRI might miss. 62 men who were considering focal therapy or prostate removal took part. The goal was to see if the new imaging could better map the cancer and help guide treatment decisions.
Matched conditions: NEOPLASMS BY SITE
Phase: PHASE2 • Sponsor: Alessandro D'Agnolo • Aim: Diagnosis
Last updated May 15, 2026 11:55 UTC